IL99097A0 - Haemophilus paragallinarum vaccine - Google Patents

Haemophilus paragallinarum vaccine

Info

Publication number
IL99097A0
IL99097A0 IL99097A IL9909791A IL99097A0 IL 99097 A0 IL99097 A0 IL 99097A0 IL 99097 A IL99097 A IL 99097A IL 9909791 A IL9909791 A IL 9909791A IL 99097 A0 IL99097 A0 IL 99097A0
Authority
IL
Israel
Prior art keywords
haemophilus paragallinarum
vaccine
paragallinarum vaccine
haemophilus
paragallinarum
Prior art date
Application number
IL99097A
Other languages
English (en)
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of IL99097A0 publication Critical patent/IL99097A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/826—Bacterial vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL99097A 1990-09-05 1991-08-06 Haemophilus paragallinarum vaccine IL99097A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90202358 1990-09-05

Publications (1)

Publication Number Publication Date
IL99097A0 true IL99097A0 (en) 1992-07-15

Family

ID=8205111

Family Applications (1)

Application Number Title Priority Date Filing Date
IL99097A IL99097A0 (en) 1990-09-05 1991-08-06 Haemophilus paragallinarum vaccine

Country Status (13)

Country Link
US (1) US5240705A (hu)
EP (1) EP0475478B1 (hu)
JP (1) JPH0592929A (hu)
KR (1) KR920006004A (hu)
CN (1) CN1059471A (hu)
AU (1) AU640516B2 (hu)
CA (1) CA2049129A1 (hu)
DE (1) DE69110997T2 (hu)
HU (2) HU210851B (hu)
IL (1) IL99097A0 (hu)
MX (1) MX9100654A (hu)
NZ (1) NZ239654A (hu)
ZA (1) ZA916237B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994005783A1 (en) * 1992-09-07 1994-03-17 Bioproperties (Australia) Pty. Limited Novel haemophilus organism and vaccines containing the same
HU219311B (en) * 1992-10-14 2001-03-28 Akzo Nobel Nv New bacterium causing poultry disease and vaccine derived thereof
GB9521568D0 (en) * 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
JPH1084969A (ja) * 1996-09-19 1998-04-07 Chemo Sero Therapeut Res Inst ヘモフィルス・パラガリナルム由来新規ポリペプチド及びその製法
US7780961B2 (en) * 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
ATE389415T1 (de) * 2002-06-19 2008-04-15 Actogenix Nv Verfahren und mittel zur erhöhung der darmabsorption
EP1560935A2 (en) * 2002-11-15 2005-08-10 VIB vzw Self-containing lactobacillus strain
WO2007063075A1 (en) 2005-11-29 2007-06-07 Actogenix Nv Induction of mucosal tolerance to antigens
CA2675297C (en) 2007-01-25 2019-05-07 Actogenix Nv Treatment of immune disease by mucosal delivery of antigens
WO2010074126A1 (ja) * 2008-12-25 2010-07-01 財団法人化学及血清療法研究所 組換え鶏伝染性コリーザワクチン及びその製造方法
CN104212736A (zh) * 2013-09-30 2014-12-17 郑州后羿制药有限公司 一种副鸡嗜血杆菌、灭活疫苗及其制备方法
CN107354114A (zh) * 2017-09-02 2017-11-17 河南省农业科学院畜牧兽医研究所 一株副鸡嗜血杆菌及其应用
CN111471619A (zh) * 2020-04-15 2020-07-31 北京家禽育种有限公司 一种用于副鸡禽杆菌实验室分离培养的培养基及其制备方法和应用
RU2752315C1 (ru) * 2020-07-31 2021-07-26 Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук" (ФГБНУ ФНЦ ВИЭВ РАН) Вакцина против гемофилеза птиц инактивированная в форме суспензии "гемовак"

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4823893B1 (hu) * 1970-12-29 1973-07-17
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
JPS6047650B2 (ja) * 1976-06-22 1985-10-23 ソニー株式会社 磁気記録媒体とその製法
JPS54113422A (en) * 1978-02-22 1979-09-05 Shionogi & Co Ltd Hemagglutinin of haemophilus gallinarum

Also Published As

Publication number Publication date
US5240705A (en) 1993-08-31
KR920006004A (ko) 1992-04-27
CA2049129A1 (en) 1992-03-06
DE69110997T2 (de) 1995-12-07
AU8347491A (en) 1992-03-12
NZ239654A (en) 1993-01-27
JPH0592929A (ja) 1993-04-16
CN1059471A (zh) 1992-03-18
AU640516B2 (en) 1993-08-26
HU210851B (en) 1995-08-28
EP0475478B1 (en) 1995-07-05
HUT61488A (en) 1993-01-28
ZA916237B (en) 1992-05-27
HU211829A9 (en) 1995-12-28
HU912864D0 (en) 1992-01-28
DE69110997D1 (de) 1995-08-10
EP0475478A1 (en) 1992-03-18
MX9100654A (es) 1992-06-05

Similar Documents

Publication Publication Date Title
GB9001766D0 (en) Vaccines
AP9200368A0 (en) Vaccine
AP9100332A0 (en) Vaccines
EP0462534A3 (en) Acellular anti-pertussis vaccines
IL99097A0 (en) Haemophilus paragallinarum vaccine
EP0474646A4 (en) Bordetella vaccines
GB8921470D0 (en) Vaccines
EP0468714A3 (en) Peptide-polysaccharide-protein conjugate vaccines
GB9104085D0 (en) Improved synchronization technique
GB8912496D0 (en) Vaccines
EP0550595A4 (en) Methods
IL95006A0 (en) Oral vaccines
GB9021004D0 (en) Acellular vaccines
GB9006097D0 (en) Vaccines
GB9011358D0 (en) Vaccines
GB9020584D0 (en) Vaccine
GB2254247B (en) Infuser
GB9119167D0 (en) Vaccines
GB9121208D0 (en) Vaccines
GB9119009D0 (en) Vaccines
GB9110067D0 (en) Vaccines
ZA928770B (en) Vaccines
GB9105993D0 (en) Vaccines
ZA926088B (en) Vaccines
IE900354L (en) Vaccine composition